Lv6
1659 积分 2023-05-26 加入
PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival
1个月前
已关闭
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
1个月前
已完结
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data
1个月前
已完结
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study
1个月前
已完结
Predicting the risk for distant metastasis in hypopharyngeal squamous cell carcinoma and assessing the survival benefit of induction therapy
2个月前
已完结
A decreased preoperative platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer
2个月前
已完结
Extraintestinal pathogenic Escherichia coli (ExPEC) O-serotype distribution and antibiotic resistance profiles among the aging population in China: A longitudinal, multi-center study
3个月前
已完结
ALyzer3D.AI: a more generalizable deep learning predictor of light chain amyloidogenicity powered by structural and evolutionary Artificial Intelligence
3个月前
已完结
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts
4个月前
已完结
A Multicenter Study of Hereditary Transthyretin Amyloidosis in China
5个月前
已完结
皖公网安备34019202002308
